Clinical epidemiology of arteriovenous fistula in 2007

Journal of Nephrology

Volumn 20, Issue 2, 2007, Pages 141-149

  Ravani, Pietro ^a,b   Spergel, Lawrence M ^c   Asif, Arif ^d   Roy Chaudhury, Prabir ^e   Besarab, Anatole ^f  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Division of Nephrology and Dialysis   (Italy)

^c Dialysis Management Medical Group   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Arteriovenous fistula; Primary failure; Risk factors; Vascular access outcomes

Indexed keywords

AGE DISTRIBUTION; ARTERIOVENOUS SHUNT; BLOOD FLOW VELOCITY; BLOOD VESSEL GRAFT; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETER; DIABETES MELLITUS; HEALTH CARE PLANNING; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY FAILURE; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SEX DIFFERENCE; TREATMENT FAILURE; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; RENAL DIALYSIS; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34447502544     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for vascular access: update 2006. Am J Kidney Dis 2006; 48 (Suppl 1): S176-S276.
2. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62: 1109-24.
3. Lee H, Manns B, Taub K, Ghali WA, Deab S, Johnson D, Donaldson C. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40:611-22.
4. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002; 61: 305-16.
5. Centers for Medicare and Medicaid. Fistula first. [cited 2007 Mar 9]. Available from: http://www.fistulafirst.org/.
6. Collins AJ, Roberts TL, Peter WL, Chen SC, Ebben J, Constantini E. United States Renal Data System assessment of the impact of the National Kidney Foundation Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis 2002; 39: 784-95.
7. US Renal Data System. USRDS 2005 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2005. [cited 2007 Mar 9]. Available from: http://www.usrds.org/adr_2005.htm.
8. CMS Office of Public Affairs. CMS launches breakthrough initiative for major improvement in care for kidney patients. March 17, 2005 [cited 2007 Mar 9]. Available from: http://www.cms.hhs.gov/media/press/ release.asp?Counter =1386.
9. Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis 2001; 38: 494-501.
10. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-55.
11. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21: 721-8.
12. Lok C, Oliver M. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial 2003; 16: 189-96.
13. McGill RL, Marcus RJ, Healy DA, Brouwer DJ, Smith BC, Sandroni SE. AV fistula rates: changing the culture of vascular access. J Vasc Access 2005; 6: 13-7.
14. Glazer S, Diesto J, Crooks P, Yeoh H, Pascual N, Selevan D, Derose S, Farooq M. Going beyond the Kidney Disease Outcomes Quality Initiative: hemodialysis access experience at Kaiser Permanente Southern California. Ann Vasc Surg 2006; 20: 75-82.
15. Quarello F, Forneris G, Borca M, Pozzato M. Do central venous catheters have advantages over arteriovenous fistulas or grafts? J Nephrol 2006; 19: 265-79.
16. Buccianti G, Alloatti S, Conte F, Pedrini L. [Census of the Italian nephrology and dialysis units: comparison between Lombardy and Piedmont]. G Ital Nefrol 2006; 23: 193-202. Italian.
17. Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S. Factors associated with the prevalence of A-V fistulas in hemodialysis patients in the HEMO Study. Kidney Int 2000; 58: 2178-85.
18. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002; 61: 2266-71.
19. O'Hare AM, Dudley RA, Hynes DM, Mcculloch CE, Navarro D, Colin P, Stroupe K, Rapp J, Johansen KL. Impact of surgeon and surgical center characteristics on choice of permanent vascular access. Kidney Int 2003; 64: 681-9.
20. http://www.usrds.org/2006/pdf/03_pt_char_06.pdf. [cited 2007 Apr 18]
21. http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2004.pdf. [cited 2007 Apr 18]
22. Centers for Medicare & Medicaid Services. 2003 annual report: End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices 2003.
23. Bonucchi D, Cappelli G, Albertazzi A. Which is the preferred vascular access in diabetic patients? A view from Europe. Nephrol Dial Transplant 2002; 17: 20-2.
24. Ravani P, Barrett B, Mandolfo S, Brunori G, Camcarini G, Imbasciati E, Malberti F. Factors associated with unsuccessful utilization and early failure of the arterio-venous fistula for hemodialysis. J Nephrol 2005; 18: 473-9.
25. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden J. Nine years' experience with internal arteriovenous fistulas for haemodialysis: a study of some factors influencing the results. Br J Surg 1977; 64: 242-6.
26. Miller PE, Tolwani A, Luscy CP, Deierhoi MH, Bailey R, Redden DT, Allon M. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56: 275-80.
27. Rodriguez JA, Armadans L, Ferrer E, Olmos A, Codina S, Bartolome J, Borrellas J, Piera L. The function of permanent vascular access. Nephrol Dial Transplant 2000; 15: 402-8.
28. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63: 346-52.
29. Feldman HI, Joffe M, Rosas SE, Burns JE, Knauss J, Brayman K. Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis 2003; 42: 1000-12.
30. Lok CE, Alton M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17: 3204-12.
31. Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int 2001; 60: 1532-9.
32. Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, Deierhoi MH, Robbin ML. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 2001; 60: 2013-20.
33. Ravani P, Marcelli D, Malberti F. Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistulas for hemodialysis. Am J Kidney Dis 2002; 40: 1264-76.
34. Wedgwood KR, Wiggins PA, Guillou PJ. A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg 1984; 71: 640-2.
35. Lomonte C, Casucci F, Antonelli M, Giammaria B, Losurdo N, Marchio G, Basile C. Is there a place for duplex screening of the brachial artery in the maturation of arteriovenous fistulas? Semin Dial 2005; 18: 243-6.
36. Besarab A, Sherman RA. The relationship of recirculation to access blood type. Am J Kidney Dis 1997; 29: 223-9.
37. Clark TWI, Cohen RA, Kwak A, Markmann JF, Stavropoulos SW, Patel AA, Soulen MC, Mondschein JI, Kobrin S, Shlansky-Goldberg RD, Trerotola SO. Salvage of nonmaturing native fistulas by using angioplasty. Radiology 2006; 242: 286-92.
38. Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal SV. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int 2005; 67: 2462-9.
39. Ravani P, Brunori G, Mandolfo S, Cancarini G, Imbasciati E, Marcelli D, Malberti F. Cardiovascular comorbidity and late referral impact arteriovenous fistola survival: a prospective multicenter study. J Am Soc Nephrol 2004; 15: 204-9.
40. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63: 323-30.
41. Saran R, Dykstra DM, Pisoni RL, Akiba T, Akizawa T, Canaud B, Chen K, Piera L, Saito A, Young EW. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004; 19: 2334-40.
42. Brunori G, Ravani P, Mandolfo S, Imbasciati E, Malberti F, Cancarini G. Fistula maturation: doesn't time matter at all? Nephrol Dial Transplant 2005; 20: 684-7.
43. Saran R, Pisoni RL, Young EW. Timing of first cannulation of arteriovenous fistula: are we waiting too long? Nephrol Dial Transplant 2005; 20: 688-90.
44. Lee T, Barker J, Allon M. Needle infiltration of arteriovenous fistulae in hemodialysis: risk factors and consequences. Am J Kidney Dis 2006; 47: 1020-6.
45. Ravani P, Malberti F. More infiltration in less mature fistulae? Am J Kidney Dis 2006; 48: 181-2.
46. van der Linden J, Lameris TW, van den Meiracker AH, de Smet AA, Blankestijn PJ, van den Dorpel MA. Forearm venous distensibility predicts successful arteriovenous fistula. Am J Kidney Dis 2006; 47: 1013-9.
47. Kim YO, Song HC, Yoon SA, Yang CW, Kim NI, Choi YJ, Lee EJ, Kim WY, Chang YS, Bang BK. Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients. Am J Kidney Dis 2003; 41: 422-8.
48. Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, Yang CW, Hsu TS, Pang JH. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 2005; 68: 1312-9.
49. Grandaliano G, Teutonico A, Allegretti A, Losappio R, Mancini A, Gesualdo L, Schena FP, Pertosa G. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int 2003; 64: 715-9.
50. Mallamaci F, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Candeia V, Scudo P, Spoto B, Testa A, Tripepi G, Tech S, Zoccali C. Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis Patients. Am J Kidney Dis 2005; 45: 702-7.
51. Knoll GA, Wells PS, Young D, Perkins SL, Pilkey RM, Clinch JJ, Rodger MA. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol 2005; 16: 1108-14.
52. Chuang YC, Chen JB, Yang LC, Kuo CY. Significance of platelet activation in vascular access survival of haemodialysis patients. Nephrol Dial Transplant 2003; 18: 947-54.